产品名称

英文名称：Atrasentan

同义词

Atrasentan、173937-91-2、ABT-627、Atrasentan [INN]、A 127722、A-147627、195704-72-4、A-127722、(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid、(+)-A 127722、CHEMBL9194、V6D7VK2215、Xinlay、(2S,3R,4S

产品性质

CAS编号：173937-91-2

分子式：C29H38N2O6

分子量：510.62

PubChem编号：159594

英文别名：Atrasentan|173937-91-2|ABT-627|Atrasentan [INN]|A 127722|A-147627|195704-72-4|A-127722|(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid|(+)-A 127722|CHEMBL9194|V6D7VK2215|Xinlay|(2S,3R,4S

英文名称：Atrasentan

生化机理：DescriptionIC50 Value 0.0551 nM (for ET A receptor) [1]Atrasentan (A-147627) is an endothelin antagonist receptor being developed at Abbott Laboratories for the treatment of prostate cancer.in vitro The combination of Atrasentan with Taxotere was more effective in the inhibition of cell viability and induction of apoptosis in LNCaP and C4-2b cells (androgen receptor positive) but not in PC-3 cells[2]. Atrasentan profoundly induced several CYPs and drμg transporters (e.g. 12-fold induction of CYP3A4 at 50 μM). It was a moderate P-gp inhibitor (IC(50) in P388/dx cells = 15.1 ± 1.6 μM) and a weak BCRP inhibitor (IC(50) in MDCKII-BCRP cells = 59.8 ± 11 μM). BCRP or P-gp overexpressing cells were slightly more resistant towards antiproliferative effects of atrasentan [5].in vivo ABT-627 did reduce the accumulation of macrophages in both stains (36 to 53%) whereas it blocked by 76% the influx of eosinophils in Balb/c but not in C57Bl/6 mice [3]. Atrasentan was administered orally via drinking water at 3 mg kg-1 per day over 28 days. All diabetic mice developed similar hyperglycaemia (27-30 mmol l-1). Atrasentan treatment significantly improved left ventricular systolic and diastolic function in response to exogenous norepinephrine, but there were no differences between genotypes [4].Clinical trial Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone . Phase2

储存温度：-20°C储存

运输条件：超低温冰袋运输

IUPAC Name：(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid

INCHI：InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1

InChi Key：MOTJMGVDPWRKOC-QPVYNBJUSA-N

Canonical SMILES：CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4

Isomeric SMILES：CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4

PubChem CID：159594

ChEMBL Ligand：CHEMBL9194

CAS Registry No.：173937-91-2

GPCRdb Ligand：atrasentan

溶解性：25°C DMSO

象形图：

信号词：Danger

危险声明：H315 Causes skin irritationH319 Causes serious eye irritationH302 Harmful if swallowedH360 May damage fertility or the unborn child

预防措施声明：P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P270,P362+P364,P330,P203,P264+P265,P301+P317,P318,P337+P317,P332+P317

产品包装